Loading...
XSES
C2PU
Market cap2.06bUSD
Apr 04, Last price  
4.26SGD
1D
0.24%
1Q
12.70%
Jan 2017
80.51%
IPO
243.55%
Name

Parkway Life Real Estate Investment Trust

Chart & Performance

D1W1MN
No data to show
P/E
29.24
P/S
19.13
EPS
0.15
Div Yield, %
3.53%
Shrs. gr., 5y
0.26%
Rev. gr., 5y
4.74%
Revenues
145m
-1.49%
16,900,00053,887,00066,679,00080,048,00087,763,00094,074,00093,693,000100,382,000102,694,000110,123,000109,881,000112,838,000115,222,000120,892,000120,705,000129,972,000147,467,000145,268,000
Net income
95m
-5.40%
68,638,00024,696,00072,937,00065,052,000102,039,000115,411,00098,279,000121,106,00066,988,00091,929,000101,464,000151,932,000123,397,00087,224,000331,878,00041,136,000100,465,00095,041,000
CFO
96m
-3.25%
12,215,00042,513,00055,007,00065,488,00066,812,00073,836,00076,433,00079,651,00082,013,00087,517,00080,746,00088,350,00089,248,00090,312,00089,862,00094,632,00099,001,00095,786,000
Dividend
Aug 02, 20240.0754 SGD/sh
Earnings
Apr 29, 2025

Profile

Parkway Life Real Estate Investment Trust (“PLife REIT”) is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
IPO date
Aug 23, 2007
Employees
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
145,268
-1.49%
147,467
13.46%
129,972
7.68%
Cost of revenue
26,751
24,574
24,195
Unusual Expense (Income)
NOPBT
118,517
122,893
105,777
NOPBT Margin
81.59%
83.34%
81.38%
Operating Taxes
6,695
7,803
7,081
Tax Rate
5.65%
6.35%
6.69%
NOPAT
111,822
115,090
98,696
Net income
95,041
-5.40%
100,465
144.23%
41,136
-87.61%
Dividends
(121,121)
(88,391)
(64,312)
Dividend yield
5.27%
3.98%
2.83%
Proceeds from repurchase of equity
180,002
BB yield
-7.83%
Debt
Debt current
17,812
53,559
56,650
Long-term debt
870,366
776,996
797,337
Deferred revenue
1,279
1,506
1,732
Other long-term liabilities
16,735
20,461
17,754
Net debt
858,707
802,056
779,549
Cash flow
Cash from operating activities
95,786
99,001
94,632
CAPEX
(49,103)
(31,036)
(63,891)
Cash from investing activities
(239,934)
(49,557)
(125,184)
Cash from financing activities
147,354
(67,919)
47,753
FCF
2,344,689
63,056
185,215
Balance
Cash
29,471
28,499
40,010
Long term investments
34,428
Excess cash
22,208
21,126
67,939
Stockholders' equity
585,258
3,021,460
Invested Capital
2,474,075
2,243,869
2,213,921
ROIC
4.74%
5.16%
4.42%
ROCE
4.72%
5.34%
4.56%
EV
Common stock shares outstanding
612,897
605,002
605,002
Price
3.75
2.18%
3.67
-2.39%
3.76
-26.71%
Market cap
2,298,364
3.51%
2,220,357
-2.39%
2,274,808
-26.71%
EV
3,157,071
3,022,413
3,866,235
EBITDA
118,517
122,893
105,777
EV/EBITDA
26.64
24.59
36.55
Interest
12,147
12,931
6,104
Interest/NOPBT
10.25%
10.52%
5.77%